Prognostic significance of complement alleles Bf and C4 in early rheumatoid arthritis

Clinical Rheumatology

Volumn 15, Issue 6, 1996, Pages 594-598

  Paimela, L ^a   Leirisalo Repo, M ^a   Lokki, M L ^b   Koskimies, S ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Complement alleles; Prognosis; Rheumatoid arthritis

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AZATHIOPRINE; COMPLEMENT; GOLD SALT; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ADULT; ALLELISM; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 0029847746     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02238550     Document Type: Article

References (29)

1. Stastny, P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978, 298, 869-871.
2. Calin, A., Elswood, J., Klouda, P.T. Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. Arthritis Rheum 1989, 32, 1221-1225.
3. Van Zeben, D., Hazes, J.M.W., Zwinderman, A.H., Cats, A., Schreuder, G.M.T., D'Amaro, J., Breedveld, F.C. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a follow-up study. Arthritis Rheum 1991, 34, 822-830
4. Rantapää-Dahlqvist, S., Beckman, G., Beckman, L. Bf and C3 complement types in rheumatoid arthritis. Hum Hered 1985, 35, 240-245.
5. Thomson, W, Sanders, P.A., Davis, M., Davidson, J., Dyer, P.A., Grennan, D.M. Complement C4B-null alleles in Felty's syndrome. Arthritis Rheum 1988, 31, 984-989.
6. Alper, C.A., Boenisch, T., Watson, L. Genetic polymorphism in human glycine-rich beta-glycoprotein. J Exp Med 1972, 135, 68-80.
7. Dyer, P., Grennan, D.M., Dodds, W., Walton, K., Read, A., Klimiuk, P., Claque, R., Harris, R. Genetic variants of properdin factor B (Bf) in rheumatoid arthritis. J Rheumatol 1985, 12, 456-457.
8. Lanchbury, J.S.S, Pal, B., Papiha, S.S. Bf and C3 polymorphisms in rheumatoid arthritis. Hum Hered 1987, 37, 144-149.
9. Alper, C.A., Awdeh, Z.L., Raum, D.D., Fleischnick, E., Yunis, E.J. Complement genes of the human major histocompatibility complex: implication for linkage disequilibrium and disease association. In: Immunogenetics, Ed.: Panayi, D., Butterworths, London, 1984, 50-91.
10. Stockman, A., Zilko, P.J., Major, G.A.C., Tait, B.D., Property, D.N., Mathews, J.D., Hannah, M.C., McCluskey, J., Muirden, K.D. Genetic markers in rheumatoid arthritis: relationship to toxicity from D-penicillamine. J Rheumatol 1986, 13, 269-273.
11. Partancn, J., Van Assendelft, A.H.W., Koskimies, S., Forsberg, S., Hakala, M., Ilonen, J. Patients with rheumatoid arthritis and gold-induced pneumonitis express two high-risk major histocompatibility complex patterns. Chest 1987, 92, 277-281.
12. Clarkson, R.W.E., Sanders, P.A., Grennan, D.M. Complement C4 null alleles as a marker of gold or D-penicillamine toxicity in the treatment of rheumatoid arthritis. Br J Rheumatol 1992, 31, 53-54.
13. Ropes, M.W., Bennett, G.A., Cobb, S., Jacox, R., Jessar, R.A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958, 9, 175-176.
14. Arnett, F.C., Edworthy, S.M., Bloch, D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31, 315-324.
15. Van der Heijde, D., Van't Hof, M.A., Van Kiel, P.L.C.M., Theunisse, L.A.M., Lubberts, E.W., Van Leeuwen, M.A., Van Rijswijk, M.H., Van de Putte L.A.B. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990, 49, 916-920.
16. Ritchie, D.M., Boyle, J.A., McInnes, J.M., Jasani, M.K., Dalakos, T.G., Grieveson, P., Buchanan, W.W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quart J Med 1968, 37, 393-406.
17. Partanen, J., Koskimies, S. Human MHC class III genes, Bf and C4. Polymorphism, complotypes and association with MHC class I genes in the Finnish population. Hum Hered 1986, 36, 269-275.
18. Amos, D., Badir, H., Boyle, W, McQueen, M., Tiilikainen, A. A simple micro-cytotoxicity test. Transplantation 1969, 7, 220-223.
19. Awdeh, Z.L., Alper, C.A. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci USA 1980, 77, 3576-3580.
20. Van Zehen, D., Giphart, M.J., Christiansen, F.T., Hoetjer, M., Meyer, E.C.M., Breedveld, F.C. Properdin factor B and complement factor C4 allotypes in rheumatoid arthritis: results of a follow-up study. Hum Immunol 1992, 33, 148-151.
21. Mötiönen, T.T. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis. Ann Rheum Dis 1988, 47, 648-653.
22. Eberhardt, K.B., Rydgren, L.C., Pettersson, H., Wollheim, F.A. Early rheumatoid arthritis - onset, course, and outcome over 2 years. Rheumatol Int 1990, 10, 135-142.
23. Clarkson, R., Bate, A.S., Grennan, D.M., Chattopadhyay, C., Sanders, P., Davis, M., Kelly, C. DQw7 and the C4B null allele in rheumatoid arthritis and Felly's syndrome. Ann Rheum Dis 1990, 49, 976-979.
24. Naama, J.K., Niven, I.P., Zoma, A., Mitchell, W.S., Whakey, K. Complement, antigen-antibody complexes and immune complex disease. J Clin Lab Immunol 1985, 17, 59-67.
25. Sanders, P.A., Thomson, W., Dyer, P.A., Grennan, D.M. Haplotypes bearing HLA-A, -B, and -DR: Bf and C4 genes in rheumatoid arthritis families. Tissue Antigens 1988, 33, 21-29.
26. Paimela, L., Leirisalo-Repo, M., Helve, T., Koskimies, S. The prognostic value of HLA DR4 and B27 antigens in early rheumatoid arthritis. Scand J Rheumatol 1993, 22, 220-224.
27. Panayi, G.S., Wooley, P.H., Batchelor, J.R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J 1978, 2, 1326-1328.
28. Wooley, P.H., Griffin, J., Panayi, G.S., Batchelor, J.R., Welsh, K.I., Gibson, T.J. HLA-DR antigens and toxic reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med 1980, 303, 300-302.
29. Dequeker, J., Van Wanghe, P., Verdict, W. A systematic survey of HLA-A, B, C and D antigens and drug toxicity in rheumatoid arthritis. J Rheumatol 1984, 11, 282-286.